Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GCDH |
| Upstream (Parents) |
|---|
| (<<) PEBP1 → GCDH |
| (<<) MAFF → GCDH |
| (<<) GPT → GCDH |
| (<<) C10orf57 → GCDH |
| Downstream (Children) |
|---|
| GCDH → PQLC2 (>>) |
| GCDH → MME (>>) |
| GCDH → SYNGR3 (>>) |
| GCDH → MTMR1 (>>) |
| GCDH → BAZ2A (>>) |
| GCDH → SLC4A10 (>>) |
| GCDH → CYP4F12 (>>) |
| GCDH → HMGN5 (>>) |
| GCDH → ARSA (>>) |
| GCDH → HCG9 (>>) |
| GCDH → DUSP21 (>>) |
| GCDH → MDK (>>) |
| GCDH → SLC16A10 (>>) |
| GCDH → SOCS2 (>>) |
| GCDH → C10orf57 (>>) |
| GCDH → PIR (>>) |
| GCDH → ZBTB48 (>>) |
| GCDH → SIKE1 (>>) |
